Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β–related cognitive decline
Blair, Nicholas I.S.
Van Bergen, Jiri M.G.
Schreiner, Simon J.
Kagerer, Sonja M.
Leh, Sandra E.
Gietl, Anton F.
Nitsch, Roger M.
Prüssmann, Klaas P.
Van Zijl, Peter C.M.
Unschuld, Paul G.
- Journal Article
Rechte / LizenzCreative Commons Attribution 4.0 International
The protracted accumulation of amyloid-β (Aβ) is a major pathologic hallmark of Alzheimer's disease and may trigger secondary pathological processes that include neurovascular damage. This study was aimed at investigating long-term effects of Aβ burden on cerebral blood volume of arterioles and pial arteries (CBVa), possibly present before manifestation of dementia. Aβ burden was assessed by 11C Pittsburgh compound-B positron emission tomography in 22 controls and 18 persons with mild cognitive impairment (MCI), [ages: 75(±6) years]. After 2 years, inflow-based vascular space occupancy at ultra-high field strength of 7-Tesla was administered for measuring CBVa, and neuropsychological testing for cognitive decline. Crushing gradients were incorporated during MR-imaging to suppress signals from fast-flowing blood in large arteries, and thereby sensitize inflow-based vascular space occupancy to CBVa in pial arteries and arterioles. CBVa was significantly elevated in MCI compared to cognitively normal controls and regional CBVa related to local Aβ deposition. For both MCI and controls, Aβ burden and follow-up CBVa in several brain regions synergistically predicted cognitive decline over 2 years. Orbitofrontal CBVa was positively associated with apolipoprotein E e4 carrier status. Increased CBVa may reflect long-term effects of region-specific pathology associated with Aβ deposition. Additional studies are needed to clarify the role of the arteriolar system and the potential of CBVa as a biomarker for Aβ-related vascular downstream pathology. Mehr anzeigen
Zeitschrift / SerieNeurobiology of Aging
Seiten / Artikelnummer
ThemaMRI; PET; CBV; 7 Tesla; Imaging; Biomarker; Vascular; Perfusion; High field; Aging; Cerebral autoregulation; Alzheimer’s disease
Organisationseinheit03628 - Prüssmann, Klaas P. / Prüssmann, Klaas P.